Amiloride is a drug used to treat high blood pressure and heart disease. Research suggested it might have a neuroprotective effect in multiple sclerosis (MS), but it was found to be ineffective.

Aromatherapy is a complementary therapy used by some people with multiple sclerosis (MS), where essential oils are used to promote wellbeing and relaxation.

Low vitamin D levels have been linked with an increased risk of getting MS, but also with more frequent relapses and increased disability in those with established multiple sclerosis.

Before a trial can recruit patients, ethical approval must be obtained. Find out how ethical reviews help safeguard and protect individuals involved in trials.

A clinical trial is a research study involving healthy individuals or people with a condition, to test new or different types of treatments.

Over 100 people walked, ran, swam, arm cycled, wheeled and more as part of our accessible fundraising challenge. We caught up with some of them to find out why they got involved and how exercise has helped them live well with MS.

Zinbryta was a disease modifying drug (DMD) used to treat relapsing remitting MS. Cases of severe side effects meant that in March 2018 it was withdrawn and is no longer being prescribed.

Laquinimod was developed as a treatment for multiple sclerosis. Following disappointing clinical trial results, the manufacturer discontinued development of it in MS.

Riluzole is a glutamate receptor blocker used in the treatment of ALS, a form of motor neurone disease.